SANDOZ LISDEXAMFETAMINE CAPSULES

Identification of Sandoz Lisdexamfetamine Capsules

No description

Google image searchProduct monograph

Active ingredient

lisdexamfetamine dimesylate, 30 MG

DIN: 02546264

Dosage form(s): CAPSULE

Route(s) of administration: ORAL

Schedule: Schedule G (CDSA I)

Company: SANDOZ CANADA INCORPORATED

Date: 23-SEP-2024

ATC:

Reference brand drug: Vyvanse

Search on Google

Sandoz Canada Incorporated

Go to Sandoz website to see drug product details. Sometimes you can find sandoz lisdexamfetamine capsules photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.